Limits...
Cancer Carepartners: Improving patients' symptom management by engaging informal caregivers.

Silveira MJ, Given CW, Cease KB, Sikorskii A, Given B, Northouse LL, Piette JD - BMC Palliat Care (2011)

Bottom Line: Both groups will receive standard oncology, hospice, and palliative care.This intervention uses readily available technology to improve patient caregiver communication about symptoms and caregiver knowledge of symptom management.NCT00983892.

View Article: PubMed Central - HTML - PubMed

Affiliation: Center for Clinical Management Research, Veteran Affairs Medical Center, Ann Arbor, MI, USA. mariajs@umich.edu.

ABSTRACT

Background: Previous studies have found that cancer patients undergoing chemotherapy can effectively manage their own symptoms when given tailored advice. This approach, however, may challenge patients with poor performance status and/or emotional distress. Our goal is to test an automated intervention that engages a friend or family member to support a patient through chemotherapy.

Methods/design: We describe the design and rationale of a randomized, controlled trial to assess the efficacy of 10 weeks of web-based caregiver alerts and tailored advice for helping a patient manage symptoms related to chemotherapy. The study aims to test the primary hypothesis that patients whose caregivers receive alerts and tailored advice will report less frequent and less severe symptoms at 10 and 14 weeks when compared to patients in the control arm; similarly, they will report better physical function, fewer outpatient visits and hospitalizations related to symptoms, and greater adherence to chemotherapy. 300 patients with solid tumors undergoing chemotherapy at two Veteran Administration oncology clinics reporting any symptom at a severity of ≥4 and a willing informal caregiver will be assigned to either 10 weeks of automated telephonic symptom assessment (ATSA) alone, or 10 weeks of ATSA plus web-based notification of symptom severity and problem solving advice to their chosen caregiver. Patients and caregivers will be surveyed at intake, 10 weeks and 14 weeks. Both groups will receive standard oncology, hospice, and palliative care.

Discussion: Patients undergoing chemotherapy experience many symptoms that they may be able to manage with the support of an activated caregiver. This intervention uses readily available technology to improve patient caregiver communication about symptoms and caregiver knowledge of symptom management. If successful, it could substantially improve the quality of life of veterans and their families during the stresses of chemotherapy without substantially increasing the cost of care.

Trial registration: NCT00983892.

No MeSH data available.


Related in: MedlinePlus

Depiction of theoretical model. CG = caregiver; CR = care recipient.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3295676&req=5

Figure 1: Depiction of theoretical model. CG = caregiver; CR = care recipient.

Mentions: The study is based on the stress-coping model which identifies the processes influencing quality of life in patients with cancer (Figure 1) [16,17]. According to this model, when a cancer patient develops a need-e.g. a symptom-s/he is able to address the need to the extent that s/he is self-efficacious and functional. The system we are evaluating improves patient self-efficacy by providing patients with tailored information about what they can do to feel better. By activating an informal caregiver to support the patient, there is an additional source of information and encouragement to promote the patient's self-efficacy. How the patient uses the information provided during automated telephonic interactions determines his/her quality of life, ability to comply with chemotherapy, and utilization of services. The proposed intervention serves not only to improve patient access to information, but also to increase the speed of information transfer between patient and caregiver.


Cancer Carepartners: Improving patients' symptom management by engaging informal caregivers.

Silveira MJ, Given CW, Cease KB, Sikorskii A, Given B, Northouse LL, Piette JD - BMC Palliat Care (2011)

Depiction of theoretical model. CG = caregiver; CR = care recipient.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3295676&req=5

Figure 1: Depiction of theoretical model. CG = caregiver; CR = care recipient.
Mentions: The study is based on the stress-coping model which identifies the processes influencing quality of life in patients with cancer (Figure 1) [16,17]. According to this model, when a cancer patient develops a need-e.g. a symptom-s/he is able to address the need to the extent that s/he is self-efficacious and functional. The system we are evaluating improves patient self-efficacy by providing patients with tailored information about what they can do to feel better. By activating an informal caregiver to support the patient, there is an additional source of information and encouragement to promote the patient's self-efficacy. How the patient uses the information provided during automated telephonic interactions determines his/her quality of life, ability to comply with chemotherapy, and utilization of services. The proposed intervention serves not only to improve patient access to information, but also to increase the speed of information transfer between patient and caregiver.

Bottom Line: Both groups will receive standard oncology, hospice, and palliative care.This intervention uses readily available technology to improve patient caregiver communication about symptoms and caregiver knowledge of symptom management.NCT00983892.

View Article: PubMed Central - HTML - PubMed

Affiliation: Center for Clinical Management Research, Veteran Affairs Medical Center, Ann Arbor, MI, USA. mariajs@umich.edu.

ABSTRACT

Background: Previous studies have found that cancer patients undergoing chemotherapy can effectively manage their own symptoms when given tailored advice. This approach, however, may challenge patients with poor performance status and/or emotional distress. Our goal is to test an automated intervention that engages a friend or family member to support a patient through chemotherapy.

Methods/design: We describe the design and rationale of a randomized, controlled trial to assess the efficacy of 10 weeks of web-based caregiver alerts and tailored advice for helping a patient manage symptoms related to chemotherapy. The study aims to test the primary hypothesis that patients whose caregivers receive alerts and tailored advice will report less frequent and less severe symptoms at 10 and 14 weeks when compared to patients in the control arm; similarly, they will report better physical function, fewer outpatient visits and hospitalizations related to symptoms, and greater adherence to chemotherapy. 300 patients with solid tumors undergoing chemotherapy at two Veteran Administration oncology clinics reporting any symptom at a severity of ≥4 and a willing informal caregiver will be assigned to either 10 weeks of automated telephonic symptom assessment (ATSA) alone, or 10 weeks of ATSA plus web-based notification of symptom severity and problem solving advice to their chosen caregiver. Patients and caregivers will be surveyed at intake, 10 weeks and 14 weeks. Both groups will receive standard oncology, hospice, and palliative care.

Discussion: Patients undergoing chemotherapy experience many symptoms that they may be able to manage with the support of an activated caregiver. This intervention uses readily available technology to improve patient caregiver communication about symptoms and caregiver knowledge of symptom management. If successful, it could substantially improve the quality of life of veterans and their families during the stresses of chemotherapy without substantially increasing the cost of care.

Trial registration: NCT00983892.

No MeSH data available.


Related in: MedlinePlus